|
SEPT7 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.782400E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.077180E-01 |
| Normal-vs-Stage2 |
2.816600E-01 |
| Normal-vs-Stage3 |
1.393840E-01 |
| Normal-vs-Stage4 |
1.945830E-01 |
| Stage1-vs-Stage2 |
8.933400E-01 |
| Stage1-vs-Stage3 |
7.359000E-01 |
| Stage1-vs-Stage4 |
8.708000E-01 |
| Stage2-vs-Stage3 |
8.829200E-01 |
| Stage2-vs-Stage4 |
9.826200E-01 |
| Stage3-vs-Stage4 |
8.402200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.172300E-02 |
| Normal-vs-AfricanAmerican |
8.067900E-02 |
| Normal-vs-Asian |
2.467400E-01 |
| Caucasian-vs-AfricanAmerican |
8.625000E-01 |
| Caucasian-vs-Asian |
8.681600E-01 |
| AfricanAmerican-vs-Asian |
9.129600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.690300E-02 |
| Normal-vs-Female |
2.678400E-03 |
| Male-vs-Female |
3.302400E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.481600E-01 |
| Normal-vs-Extreme_Weight |
1.126960E-01 |
| Normal-vs-Obese |
3.186200E-02 |
| Normal-vs-Extreme_Obese |
8.930600E-01 |
| Normal_Weight-vs-Extreme_Weight |
3.783200E-01 |
| Normal_Weight-vs-Obese |
1.632570E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.009200E-01 |
| Extreme_Weight-vs-Obese |
6.260000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.010400E-01 |
| Obese-vs-Extreme_Obese |
2.220800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.303910E-02 |
| Normal-vs-Age(41-60Yrs) |
1.103360E-03 |
| Normal-vs-Age(61-80Yrs) |
5.110000E-01 |
| Normal-vs-Age(81-100Yrs) |
7.101600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.054600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.866500E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.852590E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.583100E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.742200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.780000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.221690E-03 |
| Normal-VS-Type2 PRCC |
3.745400E-01 |
| Normal-VS-KIRP CIMP |
3.359200E-04 |
| Normal-VS-Unclassified PRCC |
9.330000E-02 |
| Type1 PRCC-VS-Type2 PRCC |
7.70920000000563E-05 |
| Type1 PRCC-VS-KIRP CIMP |
1.269810E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
8.225200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
9.446800E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
1.548470E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
1.897990E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.025800E-01 |
| Normal-vs-N1 |
2.358100E-02 |
| Normal-vs-N2 |
1.453840E-01 |
| N0-vs-N1 |
7.918200E-03 |
| N0-vs-N2 |
2.066600E-01 |
| N1-vs-N2 |
9.159600E-01 |
|
|
